Search

Your search keyword '"Bogdanet, D"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Bogdanet, D" Remove constraint Author: "Bogdanet, D"
41 results on '"Bogdanet, D"'

Search Results

4. A core outcome set for the treatment of pregnant women with pregestational diabetes: an international consensus study.

5. A core outcome set for studies of gestational diabetes mellitus prevention and treatment.

6. A core outcome set for studies of gestational diabetes mellitus prevention and treatment

7. A core outcome set for studies of gestational diabetes mellitus prevention and treatment

9. Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey

10. Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey

11. A systematic review on outcome reporting in randomised controlled trials assessing treatment interventions in pregnant women with pregestational diabetes.

12. A core outcome set for the treatment of pregnant women with pregestational diabetes: an international consensus study.

13. Early gestational diabetes mellitus (GDM) is associated with worse pregnancy outcomes compared with GDM diagnosed at 24–28 weeks gestation despite early treatment.

17. Alcohol consumption and heart failure: a dose-response meta-analysis.

18. Early Metformin in Gestational Diabetes: A Randomized Clinical Trial.

19. The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screening.

20. The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland.

21. The Role of Early Pregnancy Maternal pGCD59 Levels in Predicting Neonatal Hypoglycemia-Subanalysis of the DALI Study.

22. Reference intervals for clinical biochemistry and haematology tests during normal pregnancy.

23. The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland.

24. The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland.

25. Patient-reported outcomes (PROs) in randomised controlled trials in diabetes and pregnancy: protocol for a systematic review.

26. Atlantic DIP: is weight gain less than that recommended by IOM safe in obese women with gestational diabetes mellitus?

27. Emerging Protein Biomarkers for the Diagnosis or Prediction of Gestational Diabetes-A Scoping Review.

28. Developing a core outcome set for the treatment of pregnant women with pregestational diabetes-a study protocol.

29. Core Outcome Sets for Studies of Diabetes in Pregnancy: A Review.

30. The Oral Glucose Tolerance Test-Is It Time for a Change?-A Literature Review with an Emphasis on Pregnancy.

31. Biallelic CYP24A1 variants presenting during pregnancy: clinical and biochemical phenotypes.

32. A core outcome set for studies of gestational diabetes mellitus prevention and treatment.

33. Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns.

34. Gestational diabetes prevention and treatment: a protocol for developing core outcome sets.

35. Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey.

36. Rates of abnormal aldosterone/renin ratio in African-origin compared to European-origin patients: A retrospective study.

37. Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey.

38. The importance of standardisation of measurement and reference intervals for detection of phaeochromocytoma and paraganglioma (PPGL).

39. ATLANTIC DIP: Despite insulin therapy in women with IADPSG diagnosed GDM, desired pregnancy outcomes are still not achieved. What are we missing?

40. Endocrinopathies and renal outcomes in lithium therapy: impact of lithium toxicity.

41. ATLANTIC DIP: Insulin Therapy for Women With IADPSG-Diagnosed Gestational Diabetes Mellitus. Does It Work?

Catalog

Books, media, physical & digital resources